同期双侧初次全膝关节置换术联合氨甲环酸与限制性输血方案:仍存在五分之一的异体输血风险
该回顾性研究纳入475例接受同期双侧初次全膝关节置换术并使用双剂量氨甲环酸方案的患者,22%接受了异体输血。多因素分析显示术前血红蛋白<12.5 g/dL、女性、使用引流管是输血的危险因素。作者认为使用引流管独立增加2倍输血风险,应避免;术前血红蛋白<12.5的患者输血率约50%,应不进行同期双侧手术或进行充分的围手术期血液优化。
要点
- 同期双侧全膝关节置换术联合双剂量氨甲环酸后异体输血率为22%(106/475)。
- 术前血红蛋白<12.5 g/dL者输血率51%(42/83),≥12.5者16%(64/392),P<.001。
- 使用引流管独立增加2倍输血风险(OR=2.13,P=.004),作者认为应避免。
核心结论
- 接受同期双侧全膝关节置换术且采用当代血液管理的患者仍有约五分之一的异体输血率。
- 使用引流管独立增加2倍输血风险,应避免。
- 术前血红蛋白<12.5 g/dL的患者输血率约50%,应不进行同期双侧手术或进行充分的围手术期血液优化。
研究设计与样本
- 回顾性识别2016年至2019年单中心接受同期双侧全膝关节置换术并使用双剂量氨甲环酸方案的475例患者。
- 平均年龄65岁,女性257例(54%),平均体重指数30 kg/m²,143例(30%)使用引流管,平均术前血红蛋白13.7 g/dL。
- 采用多因素逻辑回归分析调整年龄≥70岁、性别、体重指数、引流管使用和术前血红蛋白<12.5 g/dL,以识别输血危险因素。
主要发现
- 106例(22%)接受了异体输血,其中28例(6%)接受了≥2单位。
- 多因素分析显示术前血红蛋白<12.5(OR=3.99,P<.0001)、女性(OR=2.34,P=.002)和使用引流管(OR=2.13,P=.004)是输血的危险因素。
- 术前血红蛋白<12.5的患者中42例(42/83,51%)接受了输血,而血红蛋白≥12.5的患者中64例(64/392,16%)接受了输血(P<.001)。
关键数值与推荐
- 术前血红蛋白<12.5 g/dL者输血率51%(42/83),≥12.5 g/dL者16%(64/392),P<.001。
- 术前血红蛋白<12.5的OR=3.99(P<.0001),女性OR=2.34(P=.002),使用引流管OR=2.13(P=.004)。
- 106例(22%)接受异体输血,其中28例(6%)接受≥2单位。
临床怎么用
- 作者认为使用引流管独立增加2倍输血风险,应避免。
- 作者认为术前血红蛋白<12.5 g/dL的患者应不进行同期双侧全膝关节置换术或进行充分的围手术期血液优化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Historically, there was up to a 60% risk of blood transfusion for patients undergoing simultaneous bilateral total knee arthroplasty (SBTKA). As such, the goal of this study was to analyze the rate and risk factors for allogeneic blood transfusions in patients undergoing SBTKA with tranexamic acid (TXA). METHODS: We retrospectively identified 475 patients who underwent SBTKA with a double dose TXA regimen at a single institution from 2016 to 2019. Mean age was 65 years. Two hundred fifty-seven patients (54%) were female. Mean body mass index was 30 kg/m2. Drains were utilized in 143 patients (30%). Mean preoperative hemoglobin (Hgb) was 13.7 g/dL. Multivariate logistic regression analysis adjusting for age ≥70 years, sex, body mass index, drain use, and preoperative Hgb of <12.5 g/dL was utilized to identify risk factors for transfusion. RESULTS: One hundred six patients (22%) received an allogeneic transfusion, including 28 patients (6%) who received ≥2 units. Multivariate analysis showed that preoperative Hgb <12.5 (OR = 3.99, P < .0001), female sex (OR = 2.34, P = .002), and drain use (OR = 2.13, P = .004) were risk factors for transfusion. Forty-two patients (42/83, 51%) with a preoperative Hgb <12.5 received a transfusion compared with 64 patients (64/392, 16%) with a Hgb ≥12.5 (P < .001). CONCLUSION: Patients undergoing SBTKA with contemporary blood management still have a 1 in 5 rate of allogeneic transfusion. Drain use independently increases transfusion risk by 2-fold and should be avoided. Patients with a preoperative Hgb <12.5 have a transfusion rate of 50% and, as such, should either not undergo SBTKA or have extensive perioperative blood optimization.
引用
- Chalmers BP, Mishu M, Chiu YF, et al. Simultaneous Bilateral Primary Total Knee Arthroplasty With TXA and Restrictive Transfusion Protocols: Still a 1 in 5 Risk of Allogeneic Transfusion. J Arthroplasty. 2020. PMID: 33190997. doi:10.1016/j.arth.2020.10.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。